4/A//SEC Filing
Janssen Robert 4/A
Accession 0001209191-24-002975
CIK 0001029142other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 8:41 PM ET
Size
9.3 KB
Accession
0001209191-24-002975
Insider Transaction Report
Form 4/AAmended
Janssen Robert
Chief Medical Officer and VP
Transactions
- Exercise/Conversion
Common Stock
2024-02-03+10,000→ 59,925 total - Tax Payment
Common Stock
2024-02-05$12.79/sh−4,043$51,710→ 55,882 total - Exercise/Conversion
Restricted Stock Unit
2024-02-03−10,000→ 0 total→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]Code M: Exercise or conversion of derivative security
- [F2]Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 3, 2021.
- [F3]Code F: Payment of exercise price or tax liability by delivering or withholding securities
- [F4]Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.
Documents
Issuer
DYNAVAX TECHNOLOGIES CORP
CIK 0001029142
Entity typeother
Related Parties
1- filerCIK 0001580849
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 8:41 PM ET
- Size
- 9.3 KB